Allianz Asset Management GmbH - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$405,279
-8.3%
14,7000.0%0.00%0.0%
Q2 2023$441,882
-90.8%
14,700
-89.3%
0.00%
-80.0%
Q1 2019$4,809,000
+44.8%
137,241
+37.3%
0.01%
+25.0%
Q4 2018$3,321,000
-66.7%
99,970
-49.5%
0.00%
-55.6%
Q3 2018$9,970,000
-2.5%
198,022
+15.9%
0.01%
-10.0%
Q2 2018$10,223,000
-19.9%
170,817
-38.7%
0.01%
-16.7%
Q1 2018$12,765,000
+84.3%
278,701
+60.3%
0.01%
+140.0%
Q4 2017$6,928,000
+9.9%
173,872
+10.3%
0.01%0.0%
Q3 2017$6,305,000
-55.9%
157,621
-52.5%
0.01%
-64.3%
Q2 2017$14,282,000
-15.7%
331,742
-38.7%
0.01%
-17.6%
Q1 2017$16,938,000
+28.4%
541,158
+3.6%
0.02%
+41.7%
Q4 2016$13,188,000
-10.7%
522,300
-12.6%
0.01%
-14.3%
Q3 2016$14,771,000
+93.2%
597,281
+59.1%
0.01%
+75.0%
Q2 2016$7,647,000
-23.4%
375,424
-42.7%
0.01%
-27.3%
Q1 2016$9,985,000
+13.2%
654,740
-0.2%
0.01%
+10.0%
Q4 2015$8,818,000
-4.2%
656,116
-0.0%
0.01%
-9.1%
Q3 2015$9,206,000
-15.9%
656,145
+1.8%
0.01%
-8.3%
Q2 2015$10,941,000
+300.6%
644,347
+185.3%
0.01%
+300.0%
Q1 2015$2,731,000
+51.1%
225,862
+3.7%
0.00%
+50.0%
Q4 2014$1,808,000
+1.3%
217,838
+6.1%
0.00%0.0%
Q3 2014$1,784,000
-26.4%
205,277
-7.2%
0.00%
-33.3%
Q2 2014$2,423,000221,3000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders